Literature DB >> 31776471

Hyperuricemia predicts the risk for developing hypertension independent of alcohol drinking status in men and women: the Saku study.

Yukako Tatsumi1,2,3, Kei Asayama4,5, Akiko Morimoto6, Michihiro Satoh7, Nao Sonoda6, Naomi Miyamatsu8, Yuko Ohno9, Yoshihiro Miyamoto10, Satoshi Izawa11, Takayoshi Ohkubo4,5.   

Abstract

Hyperuricemia has been reported to be a risk factor for hypertension, but this association may be affected by alcohol consumption. This study aimed to investigate whether hyperuricemia remains a risk factor for hypertension after eliminating the effect of alcohol consumption. This study comprised 7848 participants (4247 men and 3601 women) aged 30-74 years without hypertension who had undergone a medical checkup between April 2008 and March 2009 at Saku Central Hospital, Nagano Prefecture, Japan. Hyperuricemia was defined as uric acid >7.0 mg/dl in men, ≥6.0 mg/dl in women, and/or receiving treatment for hyperuricemia or gout. The incidence of hypertension was defined as the first diagnoses of blood pressure ≥140/≥ 90 mmHg and/or initiations of antihypertensive drug treatment. Multivariable-adjusted hazard ratios (HRs) of hyperuricemia for the incidence of hypertension after adjustment for and classification by alcohol consumption were estimated using the Cox proportional hazard model. During a mean of 4.0 years of follow-up, 1679 individuals developed hypertension. After adjustment for alcohol consumption, the HRs (95% confidence interval) associated with hyperuricemia were 1.37 (1.19-1.58) in men and 1.54 (1.14-2.06) in women. Among nondrinkers, the HR was 1.29 (0.94-1.78) in men with hyperuricemia compared with men without, and the corresponding HR was 1.57 (1.11-2.22) in women. The corresponding HR was 1.88 (1.27-2.86) in all participants with baseline blood pressure <120/80 mmHg. The interactions between hyperuricemia and sex (P = 0.534) and between drinking and sex (P = 0.713) were not significant. In conclusion, hyperuricemia predicts the risk for developing hypertension independent of alcohol drinking status.

Entities:  

Keywords:  Alcohol; cohort study; hypertension; hyperuricemia

Year:  2019        PMID: 31776471     DOI: 10.1038/s41440-019-0361-0

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  7 in total

1.  Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk: 2021 update.

Authors:  Claudio Borghi; Justyna Domienik-Karłowicz; Andrzej Tykarski; Krystyna Widecka; Krzysztof J Filipiak; Miłosz J Jaguszewski; Krzysztof Narkiewicz; Giuseppe Mancia
Journal:  Cardiol J       Date:  2021-01-13       Impact factor: 2.737

2.  Development of a risk prediction score for hypertension incidence using Japanese health checkup data.

Authors:  Mariko Kawasoe; Shin Kawasoe; Takuro Kubozono; Satoko Ojima; Takeko Kawabata; Yoshiyuki Ikeda; Naoya Oketani; Hironori Miyahara; Koichi Tokushige; Masaaki Miyata; Mitsuru Ohishi
Journal:  Hypertens Res       Date:  2021-12-27       Impact factor: 5.528

Review 3.  Impact of hyperuricemia on chronic kidney disease and atherosclerotic cardiovascular disease.

Authors:  Hitoshi Nishizawa; Norikazu Maeda; Iichiro Shimomura
Journal:  Hypertens Res       Date:  2022-01-19       Impact factor: 3.872

4.  The interaction on hypertension between family history and diabetes and other risk factors.

Authors:  An-le Li; Qian Peng; Yue-Qin Shao; Xiang Fang; Yi-Ying Zhang
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

5.  Effect of chronic kidney disease on the association between hyperuricemia and new-onset hypertension in the general Japanese population: ISSA-CKD study.

Authors:  Miki Kawazoe; Shunsuke Funakoshi; Shintaro Ishida; Chikara Yoshimura; Atsushi Satoh; Toshiki Maeda; Masayoshi Tsuji; Soichiro Yokota; Kazuhiro Tada; Koji Takahashi; Kenji Ito; Tetsuhiko Yasuno; Hideyuki Fujii; Shota Okutsu; Shigeaki Mukobara; Daiji Kawanami; Shigeki Nabeshima; Seiji Kondo; Kosuke Masutani; Hisatomi Arima
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-11-21       Impact factor: 3.738

6.  Prospective Study of Serum Uric Acid Levels and First Stroke Events in Chinese Adults With Hypertension.

Authors:  Feng Hu; Longlong Hu; Rihua Yu; Fengyu Han; Wei Zhou; Tao Wang; Linjuan Zhu; Xiao Huang; Huihui Bao; Xiaoshu Cheng
Journal:  Front Physiol       Date:  2021-12-23       Impact factor: 4.566

7.  The reality of treatment for hyperuricemia and gout in Japan: A historical cohort study using health insurance claims data.

Authors:  Seigo Akari; Takashi Nakamura; Kenichi Furusawa; Yuichi Miyazaki; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-07-12       Impact factor: 2.885

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.